Parkside Financial Bank & Trust’s Epizyme, Inc EPZM Stock Holding History

Parkside Financial Bank & Trust’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-530	Closed	-$3K	–	1955
2021 Q3	$3K	Hold	530	–	–	﹤0.01%	1502
2021 Q2	$4K	Hold	530	–	–	﹤0.01%	1381
2021 Q1	$5K	Hold	530	–	–	﹤0.01%	1242
2020 Q4	$6K	Hold	530	–	–	﹤0.01%	1073
2020 Q3	$6K	Hold	530	–	–	﹤0.01%	905
2020 Q2	$9K	Buy	+530	New	+$9.25K	﹤0.01%	833
2020 Q1	–	Sell	-1,825	Closed	-$45K	–	1723
2019 Q4	$45K	Hold	1,825	–	–	0.01%	460
2019 Q3	$19K	Buy	1,825 +763	+72%	+$9.62K	0.01%	642
2019 Q2	$13K	Hold	1,062	–	–	﹤0.01%	759
2019 Q1	$13K	Buy	+1,062	New	+$11.9K	﹤0.01%	723

Other funds holding EPZM

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

Parkside Financial Bank & Trust's EPZM Position: Q4 2021 in Review

Parkside Financial Bank & Trust sold out of Epizyme, Inc (EPZM) in Q4 2021, closing a stake of 530 shares — an estimated $3K sold.

Parkside Financial Bank & Trust first reported a position in EPZM in Q1 2019 and held it in 10 quarters. The position peaked at $45K in Q4 2019. 132 funds tracked by Wall St. Rank hold EPZM as of Q4 2021.

Parkside Financial Bank & Trust reported no remaining Epizyme, Inc position as of Q4 2021 after selling out during the quarter.
Parkside Financial Bank & Trust sold 530 Epizyme, Inc shares in Q4 2021, an estimated $3K.
Parkside Financial Bank & Trust first reported a position in Epizyme, Inc in Q1 2019 and held it in 10 quarters.
Parkside Financial Bank & Trust's Epizyme, Inc position peaked at $45K in Q4 2019.
132 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2021.

Based on Parkside Financial Bank & Trust's 13F filing for Q4 2021, filed 14 Feb 2022.